Roundup maker Bayer says it could stop producing the world's most popular pesticide over cancer lawsuit concerns.

Bayer's CISO, Kevin Jones, advocates for a platform-centric, shared-ownership approach to cybersecurity, emphasizing AI's role in the life science fields of healthcare and agriculture and navigating c ...

In the state with the second-highest cancer rate in the nation, the legislation would have made it harder for residents to sue pesticide companies for illnesses linked to their products.

Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...

The Trump administration has undertaken an unprecedented attack on science in regulatory, research, and educational ...

Global chemical manufacturer Bayer wants the high court to take up a Missouri case in which a gardener who used Roundup was awarded more than $1 million after developing non-Hodgkin's lymphoma.

Bayer BAYRY announced that the FDA has granted full approval to oncology drug, Vitrakvi (larotrectinib), a first-in-class TRK ...

Bayer’s Pharmaceutical Company will soon unveil a major expansion project at its Central Pennsylvania manufacturing facility, ...

Bayer Vietnam and the National Agricultural Extension Center have signed a Memorandum of Understanding in Can Tho to expand their cooperation in advancing sustainable farming practices for rice, ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric ...